Management of atrial fibrillation: focus on the role of dronedarone
Author:
Open Access
- 1 September 2011
- journal article
- review article
- Published by Taylor & Francis in Open Access Emergency Medicine
- Vol. 3, 55-68
Abstract
Peer reviewed article authored by (Cheng JW). Read article or submit your manuscript for publishing.Keywords
This publication has 30 references indexed in Scilit:
- Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA studyEP Europace, 2011
- Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial)The American Journal of Cardiology, 2011
- Dronedarone in patients with congestive heart failure: insights from ATHENAEuropean Heart Journal, 2010
- Dronedarone for atrial fibrillation: a new therapeutic agentVascular Health and Risk Management, 2009
- A Contemporary Look at Classic Trials in Atrial Fibrillation: What Do They Really Show and How Might They Apply to Future Therapies?The American Journal of Cardiology, 2008
- Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) studyAmerican Heart Journal, 2008
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterNew England Journal of Medicine, 2007
- Amiodarone versus Sotalol for Atrial FibrillationNew England Journal of Medicine, 2005
- Maintenance of sinus rhythm in patients with atrial fibrillationJACC, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002